| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.09 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.078 | 0.09 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.09 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.089 | 0.09 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.17 | 0.09 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.061 | 0.09 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.06 | 0.09 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.2 | 0.1 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |